Cerevance
PrivateLast Round
Series C
May 12, 2026
Total Funding Raised
$209.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cerevance is a biotechnology company focused on developing innovative therapeutics to create new treatments for central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerevance Comparables
Compare Cerevance with similar companies based on industry and business-model similarity.
Cerevance Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 12, 2026 | ||||
| Series B Extension | Apr 25, 2024 | ||||
| Series B Extension | Feb 13, 2023 | ||||
| Series B Extension | Jul 21, 2020 | ||||
| Series B | Apr 14, 2020 | ||||
VC Round | Feb 21, 2018 |
Cerevance Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series B Extension |
| Dolby Family Ventures | Series B Extension |
| SV Health Investors | Series C, Series A, Series B, Series B Extension, VC Round |
| GV | Series C, Series B Extension, Series B |
| Lightstone Ventures | Series C, Series B Extension, Series B, Series A |
| Bioluminescence Ventures | Series B Extension |
| Bellco Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 36% MoM.
- May 12, 2026
$20M round with participation from GV and UPMC Enterprises.
Cerevance Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cerevance's valuation, stock price, and market status.
Is Cerevance a public or private company?
Cerevance is a private company.
What is the current stock price of Cerevance?
Cerevance is a private company with no public stock price. No recent secondary market data is available.
How much is Cerevance worth (valuation)?
Valuation information for Cerevance is not publicly available.
Can I buy Cerevance stock?
Cerevance shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cerevance's last funding round?
Cerevance's most recent funding round was Series C on May 12, 2026.
Who are the main investors in Cerevance?
Key investors in Cerevance include Agent Capital, Dolby Family Ventures, GV, Lightstone Ventures, Bioluminescence Ventures.
Will Cerevance IPO soon?
No public IPO plans have been announced for Cerevance.
How can I track Cerevance secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cerevance's secondary market activity and sign up for updates.